VITROS IMMUNODIAGNOSTIC PRODUCTS PROGESTERONE REAGENT PACK 1938570

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,o report with the FDA on 2015-08-21 for VITROS IMMUNODIAGNOSTIC PRODUCTS PROGESTERONE REAGENT PACK 1938570 manufactured by Ortho-clinical Diagnostics.

Event Text Entries

[23711009] The investigation confirmed that a higher than expected vitros prog patient result was obtained using a vitros eci system when compared to the prog result obtained using an alternate prog methodology which was considered true. A definitive assignable cause could not be determined; however there was no prog qc processed on the day of the event and the vitros prog lot 2110 had expired one month prior. Laboratory protocol issues associated with not running qc prior to patient testing and using expired reagent are contributing factors to this event. There was no indication of an instrument issue; however, there was no precision testing performed to confirm this. A sample related issue, a reagent issue and/or an instrument issue cannot be ruled out as potential contributing factors to this event. Per ocd medical consult: if the patient does not experience any adverse reactions to the gonadotropins treatment, serious long term injury is not anticipated.
Patient Sequence No: 1, Text Type: N, H10


[23711010] The customer complained that a higher than expected vitros prog patient result was obtained using a vitros eci system when compared to the prog result obtained using an alternate prog methodology which was considered true. Patient result: 1. 85 ng/ml vs expected 0. 56 ng/ml. Patient fertilization treatment was postponed based on the higher than expected vitros prog result. Therefore, this was classified as a potential health and safety event because medical action was taken (fertilization treatment discontinued). There was no allegation of patient harm made as a result of this event. This report corresponds to ortho clinical diagnostics inc. Complaint number (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3007111389-2015-00272
MDR Report Key5021218
Report SourceFOREIGN,HEALTH PROFESSIONAL,O
Date Received2015-08-21
Date of Report2015-08-21
Date of Event2015-07-20
Date Mfgr Received2015-07-23
Device Manufacturer Date2014-11-21
Date Added to Maude2015-08-21
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JAMES A STEVENS
Manufacturer Street100 INDIGO CREEK DRIVE
Manufacturer CityROCHESTER NY 14626
Manufacturer CountryUS
Manufacturer Postal14626
Manufacturer Phone5854533000
Manufacturer G1ORTHO CLINICAL DIAGNOSTICS
Manufacturer StreetFELINDRE MEADOWS PENCOED
Manufacturer CityBRIDGEND, WALES CF355PZ
Manufacturer CountryUK
Manufacturer Postal CodeCF35 5PZ
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameVITROS IMMUNODIAGNOSTIC PRODUCTS PROGESTERONE REAGENT PACK
Generic NameIN-VITRO DIAGNOSTIC
Product CodeJLS
Date Received2015-08-21
Catalog Number1938570
Lot Number2110
Device Expiration Date2015-06-17
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerORTHO-CLINICAL DIAGNOSTICS
Manufacturer Address100 INDIGO CREEK DRIVE ROCHESTER NY 14626 US 14626


Patients

Patient NumberTreatmentOutcomeDate
10 2015-08-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.